Marshall Wace
CRBP icon

Marshall Wace’s Corbus Pharmaceuticals CRBP Stock Holding History

Marshall Wace’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$744K Sell
79,331
-67,265
-46% -$637K ﹤0.01% 2340
2026
Q1 		$1.38M Buy
146,596
+69,050
+89% +$581K ﹤0.01% 1977
2025
Q4 		$631K Sell
77,546
-24,963
-24% -$308K ﹤0.01% 2148
2025
Q3 		$1.3M Buy
102,509
+82,638
+416% +$786K ﹤0.01% 1823
2025
Q2 		$137K Buy
+19,871
New +$144K ﹤0.01% 2507
2024
Q4 		– Sell
-19,073
Closed -$393K – 2635
2024
Q3 		$393K Buy
+19,073
New +$976K ﹤0.01% 2012
2020
Q2 		– Sell
-11,706
Closed -$1.84M – 1608
2020
Q1 		$1.84M Buy
+11,706
New +$1.98M 0.02% 655

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Marshall Wace's CRBP Position: Q2 2026 in Review

Marshall Wace reduced its Corbus Pharmaceuticals (CRBP) stake by 46% in Q2 2026, selling an estimated $637K and leaving 79,331 shares worth $744K. The position accounts for ﹤0.01% of the portfolio, ranked #2340.

Marshall Wace first reported a position in CRBP in Q1 2020 and has held it in 7 quarters since. The position peaked at $1.84M in Q1 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Marshall Wace held 79,331 shares of Corbus Pharmaceuticals worth $744K as of Q2 2026.
  • Marshall Wace sold 67,265 Corbus Pharmaceuticals shares in Q2 2026, an estimated $637K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2340 holding.
  • Marshall Wace first reported a position in Corbus Pharmaceuticals in Q1 2020 and has held it in 7 quarters since.
  • Marshall Wace's Corbus Pharmaceuticals position peaked at $1.84M in Q1 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.